Stock Detail
ALBANY MOLECULAR RESEARCH INC
Sector: Drugs
Latest Quote @ Sat May 5 20:06:36 (15 min delayed)
| N/A |
N/A |
$11.15 |
+0.10 |
0.90% |
|
Last Day's Data
| $11.15 |
$11.22 |
$0.10 |
0.90% |
0.00 |
$11.05 |
| $11.05 |
$10.81 |
163,955.00 |
347.03M |
429,121.00 |
52.69 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 11.47 |
11.31 |
11.06 |
10.90 |
10.65 |
Stock Profile
Albany Molecular Research, Inc. operates as a chemistry-based drug discovery and development company. It develops small molecule prescription drugs. Albany offers drug lead discovery, medicinal chemistry, chemical development, and analytical chemistry services. The company conducts research and development projects; and collaborates with various pharmaceutical, biotechnology, and genomics companies. It also provides discovery technologies, including isolation, purification, structure elucidation, and sample collection libraries from microbial and botanical sources, computational chemistry, virtual screening, microbiology, fermentation, asymmetric synthesis, and high throughput metabolic screening. The company offers its services to pharmaceutical companies, biotechnology companies, agricultural companies, fine chemical companies, and contract chemical manufacturers. Albany Molecular Research was founded in 1991 and is based in Albany, New York.
